ReXceptor Inc.

Northeast Ohio
Technology Sector: 

ReXceptor is developing disease modifying small molecule therapeutics for the treatment of Alzheimer's disease and other neurological disorders. One of the hallmarks of Alzheimer’s disease is the formation of amyloid plaques in the brain, comprised mainly of amyloid beta peptides. ReXceptor aims to restore and enhance the brain’s natural clearance mechanisms of amyloid-beta by administering a retinoid X receptor (RXR) agonist.